Leucid Bio

News

CAR-T therapies have revolutionised the treatment of some blood cancers, but so far haven't been able to repeat that success in solid tumours.

News

Zymeworks has reached a deal to buy Theravance, claiming rights to COPD therapy Yupelri, sold by Viatris, which made $267m last year.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.